Literature DB >> 19135534

Novel dimerization mode of the human Bcl-2 family protein Bak, a mitochondrial apoptosis regulator.

Hongfei Wang1, Chie Takemoto, Ryogo Akasaka, Tomomi Uchikubo-Kamo, Seiichiro Kishishita, Kazutaka Murayama, Takaho Terada, Lirong Chen, Zhi-Jie Liu, Bi-Cheng Wang, Sumio Sugano, Akiko Tanaka, Makoto Inoue, Takanori Kigawa, Mikako Shirouzu, Shigeyuki Yokoyama.   

Abstract

Interactions of Bcl-2 family proteins play a regulatory role in mitochondrial apoptosis. The pro-apoptotic protein Bak resides in the outer mitochondrial membrane, and the formation of Bak homo- or heterodimers is involved in the regulation of apoptosis. The previously reported structure of the human Bak protein (residues Glu16-Gly186) revealed that a zinc ion was coordinated with two pairs of Asp160 and His164 residues from the symmetry-related molecules. This zinc-dependent homodimer was regarded as an anti-apoptotic dimer. In the present study, we determined the crystal structure of the human Bak residues Ser23-Asn185 at 2.5A, and found a distinct type of homodimerization through Cys166 disulfide bridging between the symmetry-related molecules. In the two modes of homodimerization, the molecular interfaces are completely different. In the membrane-targeted model of the S-S bridged dimer, the BH3 motifs are too close to the membrane to interact directly with the anti-apoptotic relatives, such as Bcl-x(L). Therefore, the Bak dimer structure reported here may represent a pro-apoptotic mode under oxidized conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135534     DOI: 10.1016/j.jsb.2008.12.003

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  16 in total

Review 1.  Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis.

Authors:  D Westphal; R M Kluck; G Dewson
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

2.  "Licensed to kill": tyrosine dephosphorylation and Bak activation.

Authors:  Joanna Fox; Abul Azad; Ferina Ismail; Alan Storey
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

3.  Finding the missing link: disulfide-containing proteins via a high-throughput proteomics approach.

Authors:  Ramzi J Khairallah; Sakthivel Sadayappan
Journal:  Proteomics       Date:  2013-11       Impact factor: 3.984

4.  Tyrosine dephosphorylation is required for Bak activation in apoptosis.

Authors:  Joanna L Fox; Ferina Ismail; Abul Azad; Nicola Ternette; Sabrina Leverrier; Mariola J Edelmann; Benedikt M Kessler; Irene M Leigh; Sarah Jackson; Alan Storey
Journal:  EMBO J       Date:  2010-10-19       Impact factor: 11.598

5.  Direct activation of full-length proapoptotic BAK.

Authors:  Elizaveta S Leshchiner; Craig R Braun; Gregory H Bird; Loren D Walensky
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-12       Impact factor: 11.205

Review 6.  The deadly landscape of pro-apoptotic BCL-2 proteins in the outer mitochondrial membrane.

Authors:  Mark P A Luna-Vargas; Jerry E Chipuk
Journal:  FEBS J       Date:  2016-01-06       Impact factor: 5.542

7.  Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization.

Authors:  Yuan-Ping Pang; Haiming Dai; Alyson Smith; X Wei Meng; Paula A Schneider; Scott H Kaufmann
Journal:  Sci Rep       Date:  2012-02-10       Impact factor: 4.379

Review 8.  A new view of the lethal apoptotic pore.

Authors:  Gorka Basañez; Lucian Soane; J Marie Hardwick
Journal:  PLoS Biol       Date:  2012-09-25       Impact factor: 8.029

9.  BID-induced structural changes in BAK promote apoptosis.

Authors:  Tudor Moldoveanu; Christy R Grace; Fabien Llambi; Amanda Nourse; Patrick Fitzgerald; Kalle Gehring; Richard W Kriwacki; Douglas R Green
Journal:  Nat Struct Mol Biol       Date:  2013-04-21       Impact factor: 15.369

10.  [Physiological Function and Structural Basis of Bcl-2 Family Proteins].

Authors:  冯 健愉; 朱 玉山; 权 陈; 林家 凌; Feng Jianyu; Zhu Yushan; Chen Quan; Lin Jialing
Journal:  Zhongguo Xi Bao Sheng Wu Xue Xue Bao       Date:  2019-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.